Dr. Jeffrey Silva and Dr. Matthew Stokes from Cell Signaling Technology answers questions from a recent webinar exploring the role of mass spectrometry-based proteomics on drug discovery, disease mechanisms, and biomarker identification.

For more information or to watch the webinar, click here.